Omeros (NASDAQ:OMER) specializes in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market and orphan indications. Targeting a range of diseases including those related to the immune system, inflammation, and central nervous system, Omeros is passionately involved in advancing a diverse portfolio of promising treatment options. With a focus on addressing unmet medical needs, Omeros' operations span from research and development to marketing its approved products. The company's projects aim to harness innovative science in pursuit of breakthrough therapies, evidencing its commitment to improving patients' lives. By continuously exploring novel pathways and mechanisms, Omeros strives to expand its impact across various therapeutic areas, aiming for substantial contributions to medical care and patient well-being globally.